APA (7th ed.) Citation

Gianoncelli, L., Spitaleri, G., Passaro, A., Fumagalli, C., Aliaga, P. T., Signore, E. D., . . . Marinis, F. d. (2019). 152P Correlation among different KRAS alterations, genetic co-mutations and PD-L1 expression in patients treated with immunotherapy in metastatic NSCLC. Annals of Oncology, 30, N.PAG. https://doi.org/10.1093/annonc/mdz063.050

Chicago Style (17th ed.) Citation

Gianoncelli, L., et al. "152P Correlation Among Different KRAS Alterations, Genetic Co-mutations and PD-L1 Expression in Patients Treated with Immunotherapy in Metastatic NSCLC." Annals of Oncology 30 (2019): N.PAG. https://doi.org/10.1093/annonc/mdz063.050.

MLA (9th ed.) Citation

Gianoncelli, L., et al. "152P Correlation Among Different KRAS Alterations, Genetic Co-mutations and PD-L1 Expression in Patients Treated with Immunotherapy in Metastatic NSCLC." Annals of Oncology, vol. 30, 2019, p. N.PAG, https://doi.org/10.1093/annonc/mdz063.050.